The Medibank (ASX:MPL) share price is up 18% so far in 2021. Here's why

Here's what's driven the Medibank share price this year.

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price has been having a great year so far on the ASX.

Perhaps more impressive, the health insurance and solutions company's gains have come despite it only releasing news a handful of times.

Right now, the Medibank shares are trading for $3.54 apiece, 17.28% higher than they were at the start of 2021.

Let's take a closer look at what the S&P/ASX 200 Index (ASX: XJO) company has been up to in 2021.

What's driven the Medibank share price in 2021?

It's been a good year for Medibank shares, despite the company keeping relatively quiet. Here's what we've heard from Medibank in 2021.

Myhealth acquisition

In early February, Medibank announced it had acquired a non-controlling 33.4% interest in Myhealth Medical Group.

Myhealth operates 86 primary care clinics scattered across Victoria, New South Wales, and Queensland.

According to Medibank, the investment strengthened its focus on preventive health and doctor-led partnerships.

The Medibank share price didn't react to the news.

Half yearly results

A matter of weeks later, Medibank released its results for the first half of financial year 2021.

For the 6 months ended 31 December 2020, Medibank recorded net profits after tax of $226.4 million, a 27.3% increase on those of the prior corresponding period.

It also reported that its income from premiums rose 0.3% to $3.3 billion, while its net claims expenses dropped $24.1 million – or 0.8%.

Medibank also announced a 5.8 cent fully franked dividend.

Finally, the company announced its CEO, Craig Drummond, was to retire. Medibank's new CEO David Koczkar took over the role on 17 May.

The Medibank share price fell 3.4% on the back of the results.

Returning money to customers

Lastly, in April Medibank announced that it plans to return around $105 million it's saved during COVID-19 to its customers.

According to Medibank, the savings came from its customers deferring their claims due to the global pandemic.

The Medibank share price fell 0.6% the day the company announced the give-back.

Medibank share price snapshot

After starting 2021 at $3.04, the Medibank share price is now $3.54.

It has also gained 24% since this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Polynovo shares fall despite yesterday's upbeat update. Here's what investors are watching

Polynovo shares slide after a solid update as investors wait for clearer growth signals.

Read more »

Woman flexes muscles after donating blood.
Healthcare Shares

Check out this CSL share price forecast for 2026. It's hard to believe!

RBC Capital Markets thinks CSL is a bargain at current levels.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Good news out of China has this drug company's shares higher

A major new market will open up following this approval.

Read more »